FDA Signals It’s Open To Drug Trials That Shift Midcourse

Unfortunately, you’ll need a subscription to read this WSJ article. Fortunately, I can summarize it in one sentence. The FDA is finally planning to release a guidance for the design, conduct and analysis of adaptive clinical trials. And my one-sentence commentary: It’s about freakin’ time.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • SphereIt
  • TailRank
  • Technorati
Sphere: Related Content

RSS feed for comments on this post · TrackBack URL

Leave a Comment

You must be logged in to post a comment.